[go: up one dir, main page]

AU2001279999A1 - Prevention of acute sinusitis and sinus attack - Google Patents

Prevention of acute sinusitis and sinus attack

Info

Publication number
AU2001279999A1
AU2001279999A1 AU2001279999A AU7999901A AU2001279999A1 AU 2001279999 A1 AU2001279999 A1 AU 2001279999A1 AU 2001279999 A AU2001279999 A AU 2001279999A AU 7999901 A AU7999901 A AU 7999901A AU 2001279999 A1 AU2001279999 A1 AU 2001279999A1
Authority
AU
Australia
Prior art keywords
prevention
acute sinusitis
sinus
attack
sinus attack
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001279999A
Other languages
English (en)
Inventor
James T. Angello
Howard M. Druce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU2001279999A1 publication Critical patent/AU2001279999A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001279999A 2000-09-08 2001-08-23 Prevention of acute sinusitis and sinus attack Abandoned AU2001279999A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65792900A 2000-09-08 2000-09-08
US09657929 2000-09-08
PCT/IB2001/001522 WO2002019996A2 (fr) 2000-09-08 2001-08-23 Prevention de sinusite aigue et d'attaque aux sinus

Publications (1)

Publication Number Publication Date
AU2001279999A1 true AU2001279999A1 (en) 2002-03-22

Family

ID=24639223

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001279999A Abandoned AU2001279999A1 (en) 2000-09-08 2001-08-23 Prevention of acute sinusitis and sinus attack

Country Status (7)

Country Link
EP (1) EP1317259A2 (fr)
JP (1) JP2004508324A (fr)
AU (1) AU2001279999A1 (fr)
BR (1) BR0113747A (fr)
CA (1) CA2419653A1 (fr)
MX (1) MXPA03001437A (fr)
WO (1) WO2002019996A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160324890A1 (en) * 2015-05-06 2016-11-10 Robert E. Weinstein Method and Device for Preventing Microbial Resistance

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
JPH06506684A (ja) * 1991-04-01 1994-07-28 メルク　エンド　カンパニー　インコーポレーテッド イブプロフェン−充血除去剤配合物
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
WO1998023612A1 (fr) * 1996-11-25 1998-06-04 The Procter & Gamble Company Composes 2-imidazolinylaminobenzothiazole utiles en tant qu'agonistes de l'adrenorecepteur alpha-2
DE69732244T2 (de) * 1996-11-25 2006-06-29 The Board Of Regents Of The University Of Nebraska, Lincoln Guanidyl-heterocyclische verbindungen als alpha-2 adrenoceptor agonisten
JP2001517626A (ja) * 1997-09-19 2001-10-09 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸疾患を治療するための組成物及び方法
US5948414A (en) * 1998-03-24 1999-09-07 Nouveau Technologies, Inc. Herbal based nasal spray

Also Published As

Publication number Publication date
BR0113747A (pt) 2003-06-24
JP2004508324A (ja) 2004-03-18
MXPA03001437A (es) 2005-06-03
EP1317259A2 (fr) 2003-06-11
WO2002019996A2 (fr) 2002-03-14
CA2419653A1 (fr) 2002-03-14
WO2002019996A3 (fr) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2001266068A1 (en) Treatment of mineral substrates
AU2001240978A1 (en) Glycogen phosphorylase inhibitor
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU3887900A (en) Protamine fragment compositions and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2001275420A1 (en) Bio-mediated assembly of micrometer-scale and nanometer-scale structures
AU2001280179A1 (en) Production and use of octafluoropropane
AU2002231206A1 (en) Treatment of depression
AU2002211370A1 (en) Inhibition of tgf-beta and uses thereof
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2001283586A1 (en) Enhancement of the action of anti-infective agents
AU2002230717A1 (en) Use of convergence-enabled dvd and web system
AU7601400A (en) Treatment and prevention of hepatic disorders
AU2001251115A1 (en) Use of locally applied dna fragments
AUPQ885500A0 (en) Enhancement of products
AU6769900A (en) Formation of nanometer-scale structures
AU2002243284A1 (en) Jadeite and its production
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001279999A1 (en) Prevention of acute sinusitis and sinus attack
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2002218084A1 (en) Inhibitors of thromboxane formation and action
AU2694200A (en) Itchiness-relieving agents and itchiness-relieving effect potentiators
AU2001272490A1 (en) Use of galiella lactone
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines